| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4986231
[patent_doc_number] => 20070152569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Novel benzo[b]furan derivatives and their use'
[patent_app_type] => utility
[patent_app_number] => 11/324480
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3886
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20070152569.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324480 | Novel benzo[b]furan derivatives and their use | Jan 3, 2006 | Abandoned |
Array
(
[id] => 311225
[patent_doc_number] => 07528250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-05
[patent_title] => 'Chroman derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/316044
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10290
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/528/07528250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11316044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/316044 | Chroman derivatives and uses thereof | Dec 20, 2005 | Issued |
Array
(
[id] => 5141268
[patent_doc_number] => 20070003484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules'
[patent_app_type] => utility
[patent_app_number] => 11/312238
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27417
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003484.pdf
[firstpage_image] =>[orig_patent_app_number] => 11312238
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/312238 | Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules | Dec 19, 2005 | Abandoned |
Array
(
[id] => 7597595
[patent_doc_number] => 07618982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Heteroarylpyrrolopyridinones active as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/311386
[patent_app_country] => US
[patent_app_date] => 2005-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18581
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/618/07618982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11311386
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/311386 | Heteroarylpyrrolopyridinones active as kinase inhibitors | Dec 18, 2005 | Issued |
Array
(
[id] => 479369
[patent_doc_number] => 07223874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/303125
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2152
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223874.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303125 | Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof | Dec 14, 2005 | Issued |
Array
(
[id] => 4728044
[patent_doc_number] => 20080207588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines'
[patent_app_type] => utility
[patent_app_number] => 11/814878
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12969
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814878 | Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines | Dec 8, 2005 | Abandoned |
Array
(
[id] => 169137
[patent_doc_number] => 07667054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Cytotoxic agents comprising new taxanes'
[patent_app_type] => utility
[patent_app_number] => 11/295294
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 16157
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295294
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295294 | Cytotoxic agents comprising new taxanes | Dec 5, 2005 | Issued |
Array
(
[id] => 803308
[patent_doc_number] => 07423012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/293060
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13979
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293060
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293060 | Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors | Dec 1, 2005 | Issued |
Array
(
[id] => 4803623
[patent_doc_number] => 20080015212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Inhibitors Of Akt Activity'
[patent_app_type] => utility
[patent_app_number] => 11/791418
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19256
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791418 | Inhibitors Of Akt Activity | Nov 27, 2005 | Abandoned |
Array
(
[id] => 5748472
[patent_doc_number] => 20060111404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide'
[patent_app_type] => utility
[patent_app_number] => 11/284220
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9885
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111404.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284220 | Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide | Nov 20, 2005 | Abandoned |
Array
(
[id] => 5776344
[patent_doc_number] => 20060104984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Methods and compositions for use in treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/282505
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2908
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104984.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282505 | Methods and compositions for use in treating cancer | Nov 17, 2005 | Issued |
Array
(
[id] => 5851807
[patent_doc_number] => 20060234998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Compositions and methods for treating CNS disorders'
[patent_app_type] => utility
[patent_app_number] => 11/271019
[patent_app_country] => US
[patent_app_date] => 2005-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11556
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271019 | Compositions and methods for treating CNS disorders | Nov 9, 2005 | Issued |
Array
(
[id] => 112822
[patent_doc_number] => 07713998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Nitrogenous heterocyclic compound and pharmaceutical use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/719058
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40690
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719058
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719058 | Nitrogenous heterocyclic compound and pharmaceutical use thereof | Nov 8, 2005 | Issued |
Array
(
[id] => 5866318
[patent_doc_number] => 20060100449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Integrated two-step process for the production of gamma-methyl-alpha-methylene-gamma-butyrolactone from levulinic acid and hydrogen'
[patent_app_type] => utility
[patent_app_number] => 11/270038
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2847
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270038 | Integrated two-step process for the production of gamma-methyl-alpha-methylene-gamma-butyrolactone from levulinic acid and hydrogen | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5866316
[patent_doc_number] => 20060100447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase'
[patent_app_type] => utility
[patent_app_number] => 11/270011
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4577
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270011
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270011 | Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5866317
[patent_doc_number] => 20060100448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde'
[patent_app_type] => utility
[patent_app_number] => 11/270128
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4420
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270128 | Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde | Nov 8, 2005 | Abandoned |
Array
(
[id] => 4833955
[patent_doc_number] => 20080132502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => '5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/667064
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65121
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667064 | 5-heteroaryl thiazoles and their use as PI3K inhibitors | Nov 6, 2005 | Issued |
Array
(
[id] => 5638152
[patent_doc_number] => 20060069126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Pharmaceutically active isoindoline derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/267607
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8865
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267607 | Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine | Nov 3, 2005 | Issued |
Array
(
[id] => 260059
[patent_doc_number] => 07572785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Substituted imidazoles as cannabinoid receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 11/265850
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23752
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265850 | Substituted imidazoles as cannabinoid receptor modulators | Nov 2, 2005 | Issued |
Array
(
[id] => 4516625
[patent_doc_number] => 07932394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-26
[patent_title] => 'Aryloxy-substituted benzimidazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/666555
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75224
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/932/07932394.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666555 | Aryloxy-substituted benzimidazole derivatives | Oct 31, 2005 | Issued |